Get Your Personalized Supplement StackSupplement Stack Quiz

Acerola berry concentrate

Also known as: Malpighia emarginata DC, Malpighia glabra L., Acerola, Barbados cherry, West Indian cherry, Malpighia emarginata

Overview

Acerola berry concentrate is derived from the fruit of *Malpighia emarginata*, a tropical fruit renowned for its exceptionally high vitamin C content and rich phytochemical profile, which includes flavonoids, phenolic acids, and carotenoids. It is primarily utilized as a natural source of vitamin C and antioxidants in dietary supplements and functional foods. Beyond its antioxidant properties, preclinical studies suggest potential anti-inflammatory, hepatoprotective, and anticancer applications. While there is a substantial body of in vitro and animal research supporting these effects, human clinical trials remain limited. Systematic reviews have largely focused on the genetic diversity and phytochemical variability of the plant rather than its clinical efficacy in humans. Despite the promising preclinical data, the full spectrum of its benefits and optimal usage in humans requires further investigation.

Benefits

Acerola concentrate is primarily valued as a potent natural source of vitamin C, which is crucial for supporting antioxidant defense and immune function. This benefit is well-established due to its high ascorbic acid content. Secondary effects, observed mainly in animal studies, include significant anti-inflammatory activity, evidenced by reductions in TNF-α levels, and hepatoprotective effects, indicated by a decrease in liver enzymes like ALT and AST. It has also been shown to increase the activity of endogenous antioxidant enzymes such as catalase. Furthermore, some fractions of acerola extracts have demonstrated tumor-specific cytotoxicity and the ability to reverse multidrug resistance (MDR) in cancer cell lines, suggesting a potential adjunctive role in cancer therapy. However, it is critical to note that these anticancer effects are currently limited to preclinical findings, and robust human clinical evidence is lacking. No high-quality human randomized controlled trials (RCTs) with adequate sample sizes have confirmed specific benefits in human populations.

How it works

The beneficial effects of acerola are largely attributed to its high concentration of ascorbic acid (vitamin C) and a diverse array of bioactive compounds, including flavonoids (such as quercetin and apigenin glycosides), coumarins, and phenolic acids. These compounds collectively exert potent antioxidant effects by scavenging free radicals, thereby reducing oxidative stress. They also modulate inflammatory responses by influencing the production of inflammatory cytokines like TNF-α and enhancing the activity of endogenous antioxidant enzymes, such as catalase. Additionally, specific bioactive fractions within acerola have been shown to inhibit P-glycoprotein (Pgp), a drug efflux pump implicated in multidrug resistance in cancer cells. While vitamin C is well-absorbed orally, the absorption and bioavailability of other phytochemicals from acerola are less characterized.

Side effects

Acerola is generally considered safe for consumption as a dietary supplement ingredient, with no major adverse effects widely reported in the scientific literature. Although comprehensive, high-quality human safety trials with large sample sizes are lacking, animal studies have not indicated significant toxicity even at high doses (up to several grams per kilogram of body weight). Common side effects or drug interactions are not well-documented in peer-reviewed clinical studies. However, individuals with known hypersensitivity to vitamin C or related compounds should exercise caution. While no formal contraindications have been established, the absence of extensive human safety data means that long-term, high-dose consumption should be approached with prudence. As with any supplement, it is advisable to consult a healthcare professional, especially for individuals with pre-existing medical conditions or those taking other medications.

Dosage

Currently, there are no standardized dosing guidelines for acerola berry concentrate derived from human clinical trials, primarily due to the limited number of such studies. Animal studies have utilized a wide range of oral doses, from 200 mg/kg to 5 g/kg body weight, demonstrating dose-dependent effects on markers like liver enzymes and inflammation. In commercially available human supplements, acerola concentrate is typically standardized based on its vitamin C content, often providing 50-100 mg of vitamin C per serving. This dosage is generally aligned with general recommendations for vitamin C intake rather than specific efficacy data for acerola itself. Given the lack of human-specific data, users should adhere to the manufacturer's recommended dosage on supplement labels. Upper limits and safety thresholds for acerola beyond its vitamin C content are not well-defined, emphasizing the need for further research.

FAQs

Is acerola concentrate effective as a vitamin C source?

Yes, acerola is one of the richest natural sources of vitamin C, making it highly effective for increasing vitamin C intake and supporting antioxidant defense and immune function.

Does acerola have proven anti-inflammatory or anticancer effects in humans?

Currently, evidence for anti-inflammatory and anticancer effects in humans is limited to preclinical (in vitro and animal) studies. Robust human clinical trials are needed to confirm these benefits.

Is it safe to consume acerola supplements daily?

Based on available preclinical data and general usage, acerola appears safe at typical supplement doses. However, more research is needed to fully establish long-term safety at high doses in humans.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC10889565/ – This review, including animal experiments, found that acerola leaf extract significantly reduced liver enzymes (ALT, AST) and TNF-α levels, while increasing catalase activity in rats. It identified key bioactive compounds, providing preclinical evidence for hepatoprotective and anti-inflammatory effects, though human data is lacking.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6098779/ – This review highlighted that acerola fruit fractions exhibit antioxidant, anti-inflammatory, tumor-specific cytotoxicity, and multidrug resistance reversal properties in vitro. It emphasizes acerola's richness in vitamin C and other phytonutrients, primarily based on in vitro and animal data without clinical trials.
https://www.scielo.br/j/babt/a/HYCNp6BcVnMfBdLng3yJssC/ – This systematic review of 29 studies on acerola genotypes revealed high genetic diversity, which significantly impacts the vitamin C and antioxidant content of the fruit. The findings are crucial for breeding programs and quality control in acerola production, but do not address clinical efficacy.